174 related articles for article (PubMed ID: 17323523)
21. [Severe hyperkalemia associated to the use of losartan and spironolactone: case report].
Kauffmann R; Orozco R; Venegas JC
Rev Med Chil; 2005 Aug; 133(8):947-52. PubMed ID: 16163434
[TBL] [Abstract][Full Text] [Related]
22. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone.
Berry C; McMurray J
Am J Med; 2001 Nov; 111(7):587. PubMed ID: 11705445
[No Abstract] [Full Text] [Related]
23. NSAIDs, ACE inhibitors, angiotensin II receptor antagonists, and isotretinoin: still too many pregnant women exposed.
Prescrire Int; 2010 Feb; 19(105):25. PubMed ID: 20455339
[No Abstract] [Full Text] [Related]
24. Exposure of the elderly to potential nephrotoxic drug combinations in Belgium.
Smets HL; De Haes JF; De Swaef A; Jorens PG; Verpooten GA
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):1014-9. PubMed ID: 18763247
[TBL] [Abstract][Full Text] [Related]
25. Detection of spironolactone-associated hyperkalaemia following the Randomized Aldactone Evaluation Study (RALES).
Hauben M; Reich L; Gerrits CM; Madigan D
Drug Saf; 2007; 30(12):1143-9. PubMed ID: 18035866
[TBL] [Abstract][Full Text] [Related]
26. Hyperkalaemia in congestive heart failure patients using ACE inhibitors and spironolactone.
Cruz CS; Cruz AA; Marcílio de Souza CA
Nephrol Dial Transplant; 2003 Sep; 18(9):1814-9. PubMed ID: 12937229
[TBL] [Abstract][Full Text] [Related]
27. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
[TBL] [Abstract][Full Text] [Related]
28. Calamari, Hyperkalemia, and Renin-Angiotensin System Blockade.
Janak E; Kramer H
Clin J Am Soc Nephrol; 2022 Aug; 17(8):1116-1118. PubMed ID: 35896278
[No Abstract] [Full Text] [Related]
29. Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg 2+, and Na+ concentrations in small dogs with degenerative mitral valve disease.
Thomason JD; Rockwell JE; Fallaw TK; Calvert CA
J Vet Cardiol; 2007 Nov; 9(2):103-8. PubMed ID: 17983885
[TBL] [Abstract][Full Text] [Related]
30. Spironolactone in patients with heart failure.
Larkin RJ; Atlas SA; Donohue TJ
N Engl J Med; 2000 Jan; 342(2):132-3; author reply 133-4. PubMed ID: 10636751
[No Abstract] [Full Text] [Related]
31. Avoidance of ACE inhibitors or angiotensin receptor blockers among women of childbearing potential with diabetes.
Guirguis AB; Shilliday BB; Malone RM; Pignone MP
Diabetes Res Clin Pract; 2008 Jan; 79(1):e11-2. PubMed ID: 17716774
[No Abstract] [Full Text] [Related]
32. Life-threatening hyperkalemia during combined therapy with angiotensin-converting enzyme inhibitors and spironolactone: an analysis of 25 cases.
Schepkens H; Vanholder R; Billiouw JM; Lameire N
Am J Med; 2001 Apr; 110(6):438-41. PubMed ID: 11331054
[TBL] [Abstract][Full Text] [Related]
33. Laboratory evaluation of potassium and creatinine among ambulatory patients prescribed spironolactone: are we monitoring for hyperkalemia?
Raebel MA; McClure DL; Chan KA; Simon SR; Feldstein AC; Lafata JE; Andrade SE; Gunter MJ; Nelson WW; Roblin D; Platt R
Ann Pharmacother; 2007 Feb; 41(2):193-200. PubMed ID: 17284506
[TBL] [Abstract][Full Text] [Related]
34. Tolerability of spironolactone as adjunctive treatment for heart failure in patients over 75 years of age.
Dinsdale C; Wani M; Steward J; O'Mahony MS
Age Ageing; 2005 Jul; 34(4):395-8. PubMed ID: 15955761
[No Abstract] [Full Text] [Related]
35. Life threatening hyperkalaemia with diarrhoea during ACE inhibition.
McGuigan J; Robertson S; Isles C
Emerg Med J; 2005 Feb; 22(2):154-5. PubMed ID: 15662077
[TBL] [Abstract][Full Text] [Related]
36. Life-threatening hyperkalaemia caused by angiotensin-converting enzyme-inhibitor and diuretics.
Odawara M; Asano M; Yamashita K
Diabet Med; 1997 Feb; 14(2):169-70. PubMed ID: 9047098
[No Abstract] [Full Text] [Related]
37. [The 10-minute consultation. Accidental finding: hyperkalemia. Caution with analgesics and bananas].
Lenz T
MMW Fortschr Med; 2005 Jan; 147(4):59-60. PubMed ID: 15745346
[No Abstract] [Full Text] [Related]
38. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
Furumatsu Y; Nagasawa Y; Tomida K; Mikami S; Kaneko T; Okada N; Tsubakihara Y; Imai E; Shoji T
Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
[TBL] [Abstract][Full Text] [Related]
39. Adverse effects of combination angiotensin II receptor blockers plus angiotensin-converting enzyme inhibitors for left ventricular dysfunction: a quantitative review of data from randomized clinical trials.
Phillips CO; Kashani A; Ko DK; Francis G; Krumholz HM
Arch Intern Med; 2007 Oct; 167(18):1930-6. PubMed ID: 17923591
[TBL] [Abstract][Full Text] [Related]
40. Life-threatening hyperkalaemia caused by ACE inhibitor and diuretics.
Jarman PR; Keheley AM; Mather HM
Diabet Med; 1997 Sep; 14(9):808. PubMed ID: 9300234
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
